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 Cancer cell research has been growing for decades. In the field of cancer pathology, there 
is an increasing and long-unmet need to develop a new technology for low-cost, rapid, sensitive, 
selective, label-free (i.e. direct), simple and reliable screening, diagnosis, and monitoring of live 
cancerous and normal cells in same (or similar) shape and size from the same anatomic region. For 
the first time based on an electrochemical impedance signal, the breast cancer and normal cells 
have been thus screened, diagnosed and monitored on a smart bioscaffold of entangled nanowires 
of bioceramics titanate. The bioscaffold was grown and self-assembled directly on the surface of 
implantable Ti-metal following a patent from Tian-lab, and characterized by means of SEM, XRD, 
etc. On the smart bioscaffold in aqueous solutions of phosphate buffer saline (PBS), human breast 
benign (MCF7) and aggressive (MDA-MB231) cancer cells, normal (MCF10A) cells, and colon 
cancer cells (HCT116) showed characteristic impedance highly different than that of the blank 
sensor. For two sets of mixtures each mixing the normal and cancer cells, the impedance signals 
have shifted linearly with the wide range of mixing ratios, showing the biosensor’s selectivity and 
reliability. After being treated with glucose and chemotherapeutic drug (i.e. doxorubicin or DOX), 
different breast cancer cells showed different impedance signals from their difference in glucose 
metabolisms (i.e. Warburg Effect) and in resistances to the Dox, thus-fingerprinting the cells 
easily. Based on the nanostructure chemistry, impedance equivalent circuitry and cancer cell 
biology, it’s the different cells surface binding on the nanowires, and different cancer cells 
metabolic wastes from the different treatments on the nanowires that changed the charge density 
on the scaffolding nanowire surface and in turn changed the impedance signals. This new sensor 
is believed generally expandable to quantifying and characterizing live cells and even biological 
tissues of different types in future. 
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Chapter 1. Introduction 
 
  1.1 Overview of Current Cancer Diagnosis and Research      
Breast cancer patients have been increasing in number causing a high health threat 
worldwide. According to the American Cancer Society, breast cancer is the most common non-
cutaneous cancer in women in the US. Breast cancer has a 14% mortality rate among women and 
the rate is the second highest among all types of cancer.1 Current diagnostic technology utilizes a 
combination of radiological, surgical, and pathologic assessments. Diagnosis of breast cancer is 
routinely done by mammogram, but it cannot distinguish between benign and malignant lesions. 
Mammogram also fails to detect 10% to 25% of breast cancers, because tumor detection is difficult 
in  dense breast tissue.2 A biopsy is also needed to confirm or role out cancer, and it requires 
significant sample preparation using bench top protocols. PCR and flow cytometry also have been 
used for detecting circulating cancer cells in the blood and may predict the survival rate.3 However, 
both techniques require using specific tagging system and identifying particular markers, which 
may not be expressed in some cancer subpopulations. Also, they lead to cell destruction and loss 
of cell viability. Therefore, there is a high demand to solve this issue by developing further 
advanced technology to improve sensitivity and selectivity in breast cancer detection. The 
technology should also be simple, efficient, and inexpensive.  
Recently, nanowire material has attracted attention as an excellent material to be used in 
biosensing technology. This is due to their unique properties of being semiconducting with high 
sensitivity to detect single molecule.4 Titanium oxide (TiO2)-based semiconductor nanowires can 
be grown on top of titanium metal and, in turn, it can be used as an electrode to sense cancer 
cells. These TiO2 nanowires have a band gap between 1.8 and 4.1 eV. This range reflect a 
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semiconductor property making them unique from other nanowires by having the best sensitivity 
ranges.123 Besides, TiO2-nanowires are easily fabricated, highly biocompatible and chemically 
more stable.5 Thus, TiO2-nanowires are ideal for sensing purposes.  
1.2 The Importance and Motivation  
In this study, TiO2 nanowires were used for the development of a label-free 
electrochemical biosensor on a bio-scaffold for direct detection of different live breast cancer 
cell lines (MCF7 and MDA-MB231) in vitro. Cancer cells exhibit altered local dielectric 
properties compared to normal cells.40 They have different electrical conductance and 
capacitance, which can be measured by electrical impedance scanning (EIS). Therefore, these 
observations open a new direction toward using the electrochemical properties of cancer cells 
and apply them to help in developing a prognostic tool for future diagnostic technology. This 
new method also can be potentially used in various important applications in cancer screening 
and monitoring, which are doable in vitro at ultra-low-cost and in real-time.  
1.3 Dissertation Structure  
 This dissertation consists of eight chapters. In chapter one, the introduction; it consists of 
a brief overview of current cancer diagnostic tool and the significance of this study within this 
field.  
 Chapter two, overview of cell membrane and cell metabolism, where it begins by 
explaining the function of the cells and the mass transfer across its biomembranes. The 
biomembranes structure and the surface charge influence on its functionality.  
 Chapter three, impedance cell biosensing based on nanomaterial, describes the history of 
using bioimpedance to determine the pathological tissue stage. Further, introducing nanomaterial 




Chapter four, characterization methods, an introductory about the working principles of 
instruments being used in this project. Chapter five, materials and methods, a full explanation of 
the required chemicals, material and the instrumentation and the equivalent circuitry that has 
been used, which will be presented and thoroughly explained. In chapter six, results and 
discussion and the sensing of cells by TiO2-nanowire and the interpretation of the results will be 
discussed in detail.  
Chapter seven, summarize the experimental results and conclusion. Chapter eight, the 
future work; some projects are proposed to be conducted by any interested graduate student or 

















Chapter 2. Overview of Cell membrane and Metabolism 
 
2.1 Cell Structure and Its Function 
2.1.1 Cell membrane structure 
  A cell is the smallest structural and functional biological system of an organism. It 
consists of cytoplasm and a nucleus surrounded by a plasma membrane. It can be classified into 
two categories: prokaryotic and eukaryotic. Prokaryotes can be distinguished by lacking a true 
nucleus such as in bacteria, where it can be found in animal, plant, and fungi cells. Cells differ in 
size and shapes, for example, bacteria are around 1-5 µm, while animal cells are around 10-100 
µm in diameter. Cell membrane have the main role in transporting biomolecules across its plasma 
membrane, which is related to the ratio of surface area to the volume which is quite large 6.  
 The plasma membrane is the most common structure among cells, giving the cell its 
shape and protecting its organelles. Moreover, it controls the traffic of biomolecules and ions 
across it and it has an important role in initiating certain signaling pathways and cascades to 
activate or inhibit certain cells activity in response to the external environment. It composes of 
two (4-5 nm in thickness) phospholipids layers arranging them self by having the polar head 
groups directed toward the outer and the inner membrane surrounding polar solution such as 
water, while having the hydrophobic two fatty acids (nonpolar) tails imbedded within the interior 
of the membrane, thus exhibiting amphipathic nature (Fig. 2.1) 7. The hydrocarbon chains play 
an essential role in maintaining cell fluidity and stability. Higher number of saturated chains 
(having single bonds) give more rigidity to the membrane, while kinks (double-bond between 
hydrocarbon chain will interfere with fatty acid packing resulting in a decrease in rigidity 
(increase the fluidity of the membrane). In general, biomembranes consists of different kind of 
phospholipids such as Phosphatidylcholine (lecithin) (PC), Phosphatidylethanolamine (cephalin) 
(PE), Phosphatidylserine (PS), Phosphatidylinositol (PI), and Sphingomyelin (SM). Moreover, 
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cell membrane contains glycolipids, cholesterol, and membrane proteins. Membrane proteins 
have an important role in transportation, attachment, recognition, and signal transactions. 6   
 
Figure 2.1: Illustration of a cross section of cell membrane and its major components.  
 
2.1.2 Transportation across the biomembranes 
 The plasma membrane is responsible for maintaining the hemostasis of cell by creating a 
barrier separating the cell from the exterior environment and allowing specific biomolecules to 
bypass into the cell cytoplasm keeping specific concentration and composition.8 Due to its dense 
hydrophobic core, the plasma membrane phospholipids bilayer is impermeable to water-soluble 
molecules and ions. Only gases, such as oxygen (O2) and carbon dioxide (CO2) along with small 
uncharged polar molecules, such as ethanol and urea can move freely by simple diffusion across 
the artificial pure phospholipid membrane or phospholipid mixed with cholesterol. These 
molecules can diffuse without the need of a protein carrier and thus no energy is consumed. 
Thus, the movement is down the chemical concentration gradient (the higher the concentration 
gradient of the substance, the faster the movement rate across the membrane). Ionic molecules 
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movement is controlled by electrochemical potential (gradient), which include both the 
concentration gradient and the charge gradient across the membrane.  
 Most cells’ membranes have a negative potential, meaning that the outside of the 
membrane have higher potential than inside.7 The excess in the negative charges inside the cell is 
due to the presence of the negatively charged proteins, even with the presence of more potassium 
ions concentrating inside the cell (~150mM inside to ~4mM outside).9 In contrast, the outer side 
of the membrane has higher potential due to the high concentration of sodium (~140 mM outside 
to ~5 mM inside) and other cations, such as calcium, creating a higher potential (more positive).8  
 Ion transportation across the membrane or between its cellular compartment is mediated 
by specialized membrane proteins which are transmembrane proteins composed of multiple 
membrane- spanning segments (mainly alpha helices). Such transmembrane proteins facilitate 
the movement of hydrophilic substances, such as ions without being in contact with the 
hydrophobic part of the membrane. The protein membrane transporter is being classified into 
three main groups: ATP-powered pumps, ions channels, and transporters.  
ATP-powered pumps are ATPases uses the ATP hydrolysis to get the energy to be able to 
move ions or small molecules either against the concentration gradient or the charge gradient, or 
both. This process is also known as “active transport”. Ion Channels transfer ions down their 
concentration gradient without energy consumption and this also is known as “passive 
transport”, facilitative transport, or non-gating”. However, most ion channels are controlled by 
specific chemical or electrical signal and are referred to as “gated channels”. In fact, like all other 
transporter proteins, ion channels are selective to the type of molecule they transport.8  
The third type of protein transporters, are also called “carriers”, moving a wide variety of 
ions and molecules but in lower rate compared to ion channels. It is further classified into three 
main types: Uniporter (facilitated transporter), antiporter, and symporters. Uniporter transfer a 
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single type of molecule down its concentration gradient. Glucose and amino acids are transported 
with the aid of uniporter. On the contrary, antiporters and symporters facilitate the movement of 
one type of ions against concentration gradient with the movement of another ion down its 
concentration gradient either in the same direction (symporters) or in the opposite direction 
(antiporters).  Both types can also be referred as “cotransporters” due to their ability to transport 
two or more molecules at the same time.8    
2.2 Normal vs Cancer Cell Metabolism 
2.2.1 Normal cell metabolism  
 In multicellular organisms, such as human body, cells are surrounded by blood vessels 
carrying a constant nutrient supply. Proliferation regulation is crucial to the human body survival 
especially when the nutrient level exceeds the need for cell division. Therefore, uncontrolled cell 
division is prevented by inhibiting taking up nutrient unless stimulated by stimulator, such as 
growth factor. However, cancer cells overcome this regulation by altering receptor-initiated 
growth factor. Studies have shown growing evidence that some of the cellular pathways have 
constantly been activated the nutrient uptake promoting cell survival and growth.10, 11   
 In mammalian cells, glucose is the primary source of energy and play an essential role in 
cell metabolism. Under normal conditions, one mole of glucose will undergo glycolysis and will 
end up with two molecules of pyruvate, ATP, and NADH. In the mitochondria, pyruvate will be 
utilized in Krebs cycle generating more NADH, the oxidative phosphorylation electron donor, 
generating 18-folds of ATP than in glycolysis.    
 Normally, most mammalian cells in culture depend on glucose and glutamine as the main 
supply for most of the carbon, nitrogen, and free energy. Due to this fact, cells tend to alter the 
glucose utilization of differentiated cell to meet the cell proliferation needs. For example, 
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glucose will be converted to precursors such as Acetyl-CoA for fatty acid, non-essential amino 
acids, and ribose for nucleotides.   
  2.2.2 Warburg effect and cancer cell metabolic symbiosis   
   In the 1920s, Otto Warburg reported that the tumor ascites had a high glucose 
consumption and high lactate production under normal oxygen levels. This observation named as 
the Warburg effect or aerobic glycolysis and considered a landmark of aggressive tumors.12, 13 
The phenomena appeared to be associated with an increase in the glycolysis been supported by 
molecular and functional data.14  Microarray data collected from different studies have shown 
consistently an upregulation in genes related to glucose transportation and glycolysis in a wide 
range of tumors.15-17 Glucose transporters have been reported by several studies to be 
overexpressed in breast cancer, hepatocarcinomas, lymphoblastic and others.18-20   
 The metabolic reprogramming changes the metabolic activity by enhancing glycolysis 
and restricting the Krebs cycle to lower the oxygen availability. Several regulatory pathways 
contribute to the metabolic reprogramming of tumor cells include MYC, HIF-1α, and 
PI3K/AKT/mTOR.  
 One of the main regulatory mechanism in aerobic glycolysis is by activating hypoxia-
inducible factor (HIF-1). The activation of HIF-1 alters the expression of 450 genes involved in 
glycolysis, lactate production and lactate proton excretion, iron metabolism, angiogenesis, and 
metastasis. Also, the genes involved in the upregulation of glycolytic enzymes different than 
found in normal cells, such as glucose transporter (GLUT1, GLUT3), glycolytic enzymes (HKI, 
HKII, PFK-1, ALDO-A, ALDO-C, PGK1, ENO-α, PK-M2, PFKFB-3), and enzymes related to 
the production of lactate and lactate/ proton excretion (LDH-A, MCT4).21, 22 Hypoxia also 
upregulates the production of two pyruvate dehydrogenase kinases (PDK1 and PDK2) carrying 
the phosphorylation and the inactivation of three isoforms of pyruvate dehydrogenase (PDHA1, 
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PDHA2, and PDHB) that convert pyruvate to acetyl-coA.23-26 Regulators like HIF-1 and Akt 
may play an important role in acidosis. HIF-1 also enhance the expression of intracellular pH 
(pHi) regulatory systems. These include monocarboxylate transports (MCTs), Na+/H+ 
exchangers (NHEs), proton pumps (V-ATPase), and membrane-associated and cytosolic 
carbonic anhydrases (Cas). 27 These systems are important to maintain intracellular pH for cell 
survival.      
 Tumor cells consume more glucose to secrete massive amount of lactate to toxify healthy 
cells. However, cancer cells developed a survival mechanism to adapt to acidosis (toxic 
environment). In addition, CO2 is another source of acidic extracellular pH (pHe). In the tumor 
microenvironment, carbonic anhydrase (CA) hydrate CO2 producing bicarbonate (HCO-3) and 
H+.28 Hypoxia and acidosis are usually associated, however, acidosis can be observed in 
normoxic conditions because of the Warburg effect (Figure 2.2).   
 Moreover, studies showed developing hypoxia and acidosis in the microenvironment of 
premalignant epithelial cells. The partial pressure (pO2) inside the tumor is relatively lower than 
the surrounding healthy tissue. Hypoxia and acidosis create a selective environment in which 
cells having metabolic adaptation by uncoupling glycolysis from the respiratory chain and using 
glycolysis as the main source of ATP production.29 
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Figure 2.2: Schematic drawing of cancer cell metabolism (Warburg effect). 
 
 In tumor cell populations the oxygen level varies generating well-oxygenated regions 
(aerobic) and poor oxygenated (hypoxic) regions. Some studies revealed the fact that tumor cell 
can change from hypoxic to normoxic conditions and vice versa in a very short period of time 
and this can be called “metabolic symbiosis”.30-32  In the hypoxic conditions, cancer cells 
increase the expression of GLUT-1, which is activated by HIF-1. Increasing the glucose flux, in 
turn, increases the lactate production that needed to be secreted to prevent intracellular 
acidification thought the monocarboxylate 4 system (MCT4), a lactate transporter coupled to H+. 
On the contrary, cancer cells growing under normal oxygen level will take lactate instead of 
glucose supporting the metabolic symbiont concept. In aerobic cancer cells, MCT-1 transport 
lactate into the cell to be converted to pyruvate via lactate dehydrogenase B (LDHB). Krebs 
cycle and its products will be oxidized through the Krebs cycle (OXPHOS pathway) for energy 
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production. Inhibiting MTC-1 will make aerobic cancer cells to consume more glucose than 
lactate, breaking the metabolism symbiosis, leading the apoptosis of anaerobic tumor cells due to 
glucose deprivation. MCT1 expression found to be exclusively in aerobic regions of human 
tumor tissue from the head, neck, breast, and colon cancer. The result came along with the 
expression of LDHB allowing the lactate utilization as a source of energy.29 The phenomena 
were observed in murine mice model in which hypoxic tumor death was induced due to the 
inhibition of MCT1 as a treatment from lung cancer. 29 This observation is critical to treat 
patients, because blocking MCT1 in cancer cells allows chemotherapy and radiation treatment to 
be more effective, especially in reaching the hypoxic zone within the tumor region. 33 
  To conclude, acidosis promote selective checkpoints of both cell cycle and apoptotic 
mechanism.34 After several cell generation, acidosis select the most resistance phenotype for 
higher invasion and metastasis.35 Acidosis will also facilitate the extracellular matrix degradation 
to increase the cancer invasiveness leading to cancer spread (metastasis) through the circulatory 
system and ultimately patient death.35  Therefore, diagnosis and treatment are critical to be done 











Chapter 3. Impedance Cell Biosensing Based on Nanomaterial  
 
3.1 Cell Biosensing Using Impedance 
Electrochemical Impedance Spectroscopy (EIS) is a well-established and widely used 
technique in the biosensor’s development. EIS is highly a sensitive technology that uses 
alternative current (AC) for detecting electrochemical phenomena over a wide range of 
frequencies. This can be used as an electrochemical detection tool that is well known to be 
simple, free label, real-time, and at low-cost.36, 37 Since the 1920s many research studies have 
concluded that malignant breast tumors have a significantly different electrical impedance or 
electro potential values compared to those of normal tissues and benign lesions, and such 
properties are used to distinguish different tissues based on distinct electrophysiology 
characterization of a particular tissue in the frequency domain.3, 38  Among all conducted studies, 
the main focus is on studying pathological tissues. 39, 40 The EIS approach offers new cancer 
detection technique of a variety of cancers in the liver41, skin42, and breast42, and the topic has 
been discussed extensively in the literature reviews.36, 43-45  
 In 1984, Pethig 46 attempted to review the dielectric properties of tissues and 
biomolecules. The review included various research studies which have, at a molecular level, 
tried to analyze the dielectric properties characteristics of malignant breast tissues that may be 
different in between normal and malignant breast tissue’s properties. Some of the characteristics 
stated include higher water content and sodium concentration of cancerous cells, different 
electrochemical properties of their cell membranes, and reduced membrane potentials. Normal 
epithelial cells are electrically polarized by an ionic gradient across the cell membrane, and  the 
charge gradient between the apical and basolateral cell membrane is known as trans- epithelial 
electro-potential.47,48 Na+/K+ ATPase pump maintains the electrical gradient across the 
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membrane. This electrical gradient difference creates a trans-epithelial potential difference of 30 










Figure 3.1: Illustration of electrical gradient across the cell membrane.  
 
When epithelial cells divide, the charge is dissipated, creating an electrical 
depolarization. Therefore, the development of breast cancer will cause the cells to divide even 
faster resulting in generating pockets of relative depolarization. Further, when the tumor 
becomes invasive, it starts to destroy the ductal structure, thus increasing the permeability of 
ions. This differential in electrical potential can be detected at the skin surface and can be used as 
a diagnostic tool. Other studies 49-52 have used the membrane permeability, cellular water, salt 
content, packing density, and cell orientation within the malignant tissue to identify cancer 
lesions. In addition, any studies so far have confirmed that the impedance test can be used as a 
tissue differentiation tool using specified frequency range.  
 Similarly, at the cellular level, electrical properties of the cell may vary depending on 
biochemical changes caused by the disease.53 Electrical Cell-substrate Impedance Sensing 







(ECIS) was first introduced as a noninvasive method by Giaever and Keese to study the 
properties of cell attachment.54 The cell contains an intracellular medium surrounded by a 
semipermeable membrane, which separates the extracellular from the intracellular ionic 
solutions, and both are resistive in nature. The cell membrane as we discussed earlier is made 
from a lipid bilayer, proteins, and some polysaccharides. The membrane exhibits capacitive 
properties due to the presence of the potential difference. The impedance of cell membrane 
capacitance changes corresponding to the frequency. At low frequency, the cell membrane act as 
an insulator preventing the current to flow through the membrane, and lead to have a higher 
impedance level, i.e. highly resistive. When the frequency tends to be higher, the cell membrane 
act as a capacitor and start to conduct and allow the current to go through the membrane 
resulting in a lower impedance level.55       
Since it is clear that the frequency can distinguish tissues pathological stages, scientists, 
when plotting relative permittivity against the frequency, observed three distinct regions called 
alpha (f <1000 Hz), beta (1000 Hz < f < 100 MHz) and gamma (f > 1 GHz) regions. 53, 56, 57  Blad 
et al. 40 reported that alpha and beta regions are the best to detect cancerous cell electrical 
properties that are different from normal cells.     
 Further, such biochemical changes can be detected through electrical impedance (EI) 
sensing of cell-substrate interaction.58, 59 A cell suspension analysis conducted by Han et al.60 
using a sophisticated chamber showed that significant differences occur in the phase angle and 
magnitude of corresponding impedance over the frequency range of 100 Hz to 3 MHz in non-
tumorigenic MCF10A, MCF7 (non-invasive cancer cell line), MDA-MB231 and MDA-MB435 
(invasive cancer cell line). Also, the membrane capacitance and resistance differences were 
reported among those cell lines. Yang et al.61 conducted a real-time impedance-based 
measurements of cellular activities using RT-CES system to distinguish OSCC cell line and the 
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non-cancerous epithelial esophageal Het-1A cell line. Qiao et al.62 reported differences in the 
impedance measurements in both suspension of MDA-MB231 and MCF10A breast cells using a 
platinum needle as an electrode. Nwankire et al.63 created a centrifugal microfluidic system by 
using a platform on a  five-layered disc attached to a gold electrode functionalized with anti-
EpCAM  to quantify ovarian cancer cells (SKOV3) extracted from a blood sample using EIS. 
Thus, such studies have shown that impedance spectroscopy (EIS) is a powerful technique for 
distinguishing cancerous cell electrical properties from normal cell electrical properties.      
 Furthermore, electric cell-substrate impedance (ECIS) has been used to reflect various 
cells properties and behavior including attachment 64 and spreading65-67, motility68-70, and 
proliferation.71 This approach can be also used to monitor cell response to drug treatment and 
cytotoxicity assessment in real-time.72-74 Impedance- cell-based biosensors is further applied to 
identify active molecular targets involved in various diseases.72 It is also involved in detecting 
the drug toxicity and efficacy at a cellular level with nanoscale resolution.75  
Kuo et al. studied the invasive properties of human breast cancer cells (MDA-MB 435) 
into human umbilical vein endothelial cells (HUVEC) 76. MDA-MB 435 cells were treated with 
transforming growth factor (TGF)-ß and added to HUVEC monolayer. In one hour, MDA-MB 
435 invaded HUVEC resulting in decreasing the resistivity after 4 hours. The study also 
demonstrated the cellular role of (TGF)-ß in activating mambrane type 1-matrix 
metalloprotenase (MT1- MMP), which mediates the cleavage of CD44 to the soluble form. 
CD44, in turn, plays an important role in cancer cell migration.  
Recently, Stanica et al. used ECIS to evaluate hypoxia-induced bioeffect including pH on 
the tumor microenviroment using a multiplexing module (8 channels) on human colon cancer 
HT-29 cell line. 77 The study revealed a dynamic change of cellular responses during hypoxic 
condition and in response to acetazolamide (AZA), a carbonic anhydrase inhibitor.28 
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In conclusion, biosensors that utilize the electrochemical impedance technique present a 
unique technology with a great potential to meet the rapid, real-time need for breast cancer 
detection. It is important to point out that all metal electrodes in these studies are used without 
any further surface modification, which can improve the detection sensitivity. Surface 
modifications using different materials is a new direction that our group is being introduced in 
this study.   
3.2   Nanostructured Biomaterials and Biosensors 
3.2.1 Development of nanostructured biomaterials 
 Nanomaterials can be referred as nanostructured materials, which have a size between 1 
and 100 nm. These nanomaterials offer new properties compared to their bulk compartments and 
are being used for developing new applications and devices to improve our daily life. In recent 
years, a wide range of nanomaterials have been developed such as nanowires (NW), nanotubes 
(NT), nano roads (NR), nanoparticles (NP), nanoflowers (NF), nanoshell (NS), nanocages (NC). 
These nanostructured materials have established a new field called “Nanotechnology”. 
Nanotechnology is defined as the field that studies materials to be synthesized, controlled, and 
manipulated in nanometer size range. It is a rapidly growing field aiming to develop 
multifunctional systems targeting, diagnosing, and treating devastating diseases such as cancer. 
Nano-sized objects are carrying novel properties and functions that open the doors for creative 
biomaterials to be used in biomedical applications. For example, medicinal and structural 
chemists have been creating and manipulating nanometer- and sub-nanometer-sized components 
of drugs for decades and will continue to do so into the foreseeable future. A “Nano bullet for 
Tumors” is a good example of how research from diverse sources can utilize nanoparticles to 
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target cancer cells.78 The field showed promising developmental stages to design and create new 
nanomaterials and technology to achieve the desired goal.     
 
3.2.2   Nanofibrous bioscaffolds as extracellular matrix analogues 
 The extra cellular matrix (ECM) is a mesh network composed of both mechanical and 
functional proteins, being unique tissue-specific assembled architecture. It provides both a 
mechanical and functional substrate for cell signaling. The dynamic signaling of ECM is a key 
role in tissue development and homeostasis.79 The synthetic nanofibrous scaffolds are designed 
to provide a supportive framework for cell proliferation and survival, mimicking the ECM.80, 81  
The ideal scaffold would promote cell attachment, proliferation, and differentiation. Earlier 
studies showed the vital role for self-assembled peptide nanofibrous bio-scaffold to connect the 
natural ECM and promote cell regeneration corresponding to a lesion.82, 83  To date, fabrication 
of nanofibrous bioscaffolds can be achieved through mainly four techniques: electro-chemical 
dip-in lithography, mechanical stretching 84, template-directed electrochemical synthesis, and 
electrospinning.4, 85-87 The most well-known technique to produce nanofibers is called 
electrospinning.85, 88 This method uses a microfabricated scanned tip, which is dipped in a 
polymer solution to get a droplet as a source of material. Applying a sufficiently high voltage to 
the tip generates a Tylor cone and a polymer will be extracted. Moving the tip, acting as a 
counter-electrode, allows the nanofibers deposition on a substrate surface structure for 
fabrication. Beside fabrication, electrospinning can also produce oriented polymeric self-
assembled nanofibers.89-91 The diameter of the nanofibers can be controlled using various 
methods.92-94 Furthermore, nanofibrous bioscaffolds can be modified and functionalized with 
bioactive molecules to mimic the architecture of the extracellular matrix and promote cell 
outgrowth. The designed structure, composition, morphology will ultimately impact the cell 
 
 18 
adhesion, proliferation, spreading, migration, differentiation corresponding to biochemical 
signals.95, 96 Several studies discussed the mechanical strength and evaluation through theoretical 
modeling of such nanofibrous assemblies and the challenges upon developing/forwarding the 
technology toward the clinical settings.79 The fibrous alignment also showed significant results 
in enhancing mouse embryonic stem cells (ESCs) differentiation into neural cells and further 
outgrowth compared to the random nanofibrous alignment.97 A better understanding of the 
synthetic scaffold materials in supporting different injury sites will improve their usage and 
ultimately their clinical outcomes.   
 It is well known that human cells generate biological electrical field through voltage 
gradient of 10-90 mv across the cell’s membrane. This gradient initiate cell signaling, which 
alters cell proliferation and differentiation. This phenomenon inspired researches to develop 
electroactive polymers to generate electrical stimulation for repairing injured tissues. Up to date, 
a few studies showed a promising electroconductivity capability of the biocompatible scaffold. 
Researchers have demonstrated the ability of these polymers to trigger cell proliferation and 
differentiation corresponding to material’s electrical conduction.91, 98 Common electroconductive 
polymers include polyacetylene (PE), polyaniline (PANI), polypyrrole (PPy), polythiophene 
(PT) , poly(para-phenylene vinylene) (PPV), and Poly(3,4-ethylene dioxythiophene) (PEDOT) 
.99  Piezoelectric polymers include Polyhydroxybutyrate (PHB), Polyvinylidene fluoride (PVDF), 
and Poly(L-lactic acid) (PLLA), as well as polyelectrolyte gels. Bangar et al. used 
dielectrophoretically aligned Polypyrrole (PPy) nanowires across a pair of gold electrode, 
separated by 3 µm gap, for detecting cancer antigen 125 (CA 125) by corresponding antibody. 100 
The immunosensor showed good sensitivity in low concertation (1 U/mL) as well as in higher 
concentration (1000 U/mL). Although Ppy showed high sensitivity, it would be critical to know 
the chemical stability of the polymer after several uses.   
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 Electroconductive polymers are also used to trigger neural, muscular, skeletal, and 
cartilage cells differentiation and proliferation.91  However, the valid range of electrical 
stimulation is not well defined. Therefore, more fundamental in vitro and in vivo studies are 
highly needed to determine how different tissues respond to electrical stimulation. Another 
challenge is how to promote a multi-tissue regeneration using such synthetic electroactive 
scaffold in vivo with large animal models. Further studies should focus on investigating the 
combination of both chemical recognition and conductive material, through ion-exchange or 
electron transfer, which can be further applied in real-time for cell electrochemical sensing.99   
 3.3 TiO2-Based Nanostructured Bioceramics   
3.3.1 Syntheses of TiO2 –based nanostructures  
 TiO2-nanostructured material has been synthesized through several methods: template 
synthesis101, nano-seeding102, nanocoating103, electrospinning104, and hydrothermal synthesis5, 105 
(Fig. 3.2). The template synthesis includes sol-gel template, sol-gel coating, polymer mold, 
direct deposition, and super-molecular assembled process, in which a well-controlled length and 
diameter TiO2 nanowire is aligned on a substrate.106-108 The electrochemical nano-seeding 
include direct anodization of Ti foil in an H2O-HF electrolyte at room temperature or seeding Ti 
substrate with the TiO2 nanoparticle.109, 110 The nanocoating synthesis Ti substrate is performed 
by the Galvano dynamic anodizations.111 Alkaline hydrothermal synthesis was reported by Dong 
et al, where Ti metal oxidation (corrosion) occur in a large-scale solution fabrication (NaOH or 
KOH) at relatively low temperature. The nanowire root inside the Ti substrate was attached 
firmly by an unusual downward growth, while the nanowire tip grows upward to self-assemble 
to form the scaffold.112 The scaffold, reported by Dong et al, is composed of macropores of 2-10 
µm in diameter promoting cell adhesion and proliferation, controlled drug release, photocatalytic 
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sterilization, and electrochemical detection, which was an ideal multifunctional Titanium-based 
implant.5  
 
Fig. 3.2: Schematic for common synthesis methods of nanostructured TiO2.  
 
3.3.2 Commonly seen nanostructures and dimensions of TiO2- based bioceramics   
 Many studies showed that titanate can be formed in different shapes and dimensions. 
Fig.3.3 shows a summary of different TiO2 nanostructure morphology and dimensions: zero-
dimension, one-dimension, two-dimension, and three dimensions. Nanoparticles considered an 
example of zero-dimension. Nanorods, fibers, tube, and belts are examples of one-dimension. 
Nanoplates and sheets are a two-dimension structure. Due to the flexibility and diversity of 
titanate structure, it considered as an excellent platform to incorporate other materials such as 
metal oxides or transition metals113, 114, noble metals115, 116, and carbon-based material117, 118. The 
surface properties of these composite are entirely different from the bulk material, due to the 




Fig. 3.3: Schematic diagram of TiO2 of different dimensional structure.   
 
3.3.3 Properties and applications of TiO2–based nanobioceramics 
 Alkali TiO2 is the most common form of TiO2 with the formula A2TinO2n+1 (A= Li, K, 
Na). They are characterized by a large surface area with unique layers and tunnel crystalline 
structures.120-122 It has been used for a long time as a white pigment in paint. After the discovery 
of its photolytic activity on water under the UV light in the late 1970s 123, the field of TiO2-
based nanomaterial was established.124  The TiO2 structure known as “Zwitterionic”, meaning 
that it consists of multilayers with negative charges and positive charge interlayers while 
maintaining a zero-net charge for the overall structure (Fig.3.4).  
The titanate has (TiO6) octahedron as the main building block.125-127 The edge shared (TiO6) 
structure will for a negatively charged nanolayer structure. The cations (e.g. Na+) will fill the 
adjacent layered spaces. The distance between the layers will depend on the type of cation (size) 
and the hydration degree of the cation, which results in the flexibility characteristics of the long 
nanofiber. Sodium titanate (Na4O4Ti) has been used in various fields including environmental, 




Figure 3.4: Illustration of layered TiO2 crystal structure  
 
 
Figure 3.5: Schematic diagram of TiO2 applications.  
  
The ability of TiO2- based material to merge into various field came from its unique 
chemical and physical properties. These properties include low toxicity, biocompatibility, 
thermal/chemical/photochemical stability, optical transparency, and large surface area. 
Moreover, the layered titanate nanomaterial is capable of cation intercalation. Meaning that the 
material allows the process of ion exchange, which has been studied using alkali metals75 cations 
and transition-metal-ions76. The interlayered distance remained the same after intercalating with 
alkali metal cations (Na, K, Li, Rb, Cs) in aqueous solution.75 Magnetic and optical properties 
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can be further tuned using different transition-metal cations (Ag+, Cu2+, Co2+, Ni2+, Zn2+, Cd2+) 
by stirring the material in different transition-metal solutions. 76 Based on this, titanites could be 
potentially a good candidate as an electrode material for a number of reasons including (i) easy 
charge diffusion in to a short distance to reach inter-layer position, (ii) alkali ions in between the 
titanate layers can be exchanged with other cations as described earlier, and (iii) cyclic stability 
can be boosted by the intercalation process of ions to modify the layered structure and enhance 
detection sensitivity.  
3.4 Biosensors Based on Nanowires 
 A biosensor is an analytic device used for biological sample analysis. Its main role is to 
convert response, either chemical, biological, or biochemical, into an electrical signal 
proportional to the analyte concentration in the reaction.128, 129 Biosensor application are for 
pollutants, pathogenic microorganism, disease-causing biomarkers detection, or drug monitoring. 
A typical biosensor system (Fig 3.6) is composed of the following:   
• Analyte: The molecule or the complex compound being detected in the sample. For 
example, glucose is a simple molecule to be detected in glucose sensor form body fluids 
(blood, urine, saliva). Hormones, cells, and pathogenic bacteria are also examples of 
complexed subjects that can be detected by biosensors.    
• Recognizer: The part of biosensor that recognizes the interested analyte is also known as 
bioreceptor. Enzymes and antibodies are a good example for bioreceptors. Upon the 
interaction, a signal will be generated (inform of pH change, heat, light, charge or mass 




Figure 3.6: Schematic illustration of a typical biosensor.  
 
• Transducer: Is the equipment that converts the signal from one form to another. In 
biosensor, the signal can be converted from chemical to electrical or optical signal and 
this is known as signalization. The amount of signal is proportional to the amount of 
analyte in the sample  
• Converter: It consists of complex electronic circuitry and responsible for converting the 
signals from analogs to digital form preparing it to be quantified.  
• Display: The part responsible for generating the results in an understandable and user-
friendly manner. The results will be shown as numbers or graphs on a computer screen.  
The following criteria must be implemented to construct a successful biosensor:130  
• Selectivity: it is reflected by the ability of the biosensor to detect a specific analyte in a 
sample containing a mixture of other analytes or contaminants. Antibody-antigen 
interaction is the best example of high selectivity. Usually, the antibody will be 
immobilized on the surface of the transducer and the antigen will be present in the 
sample and will interact with its specific antibody to generate the signal.   
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• Sensitivity: It is also known as the limit of detection (LOD), which is the minimum 
amount of analyte can be detected by the system. In case of simple molecule analyses, 
the detection range should reach as low as ng/mL or fg/mL. For example, prostate-
specific antigen (PSA) will be present at low concentration in the blood (4pg/mL) as a 
characteristic of prostate cancer. Therefore, sensitivity is crucial for an effective 
biosensor. 
• Stability (shelf-life): Is the degree of consistency and the ability to avoid any destruction 
in and around the biosensor. Any disturbance can cause an error and a shift in the signal 
being measured. The interaction between the analyte and the bioreceptor should be a 
strong electrostatic bounding or a covalent linkage to ensure the stability of the system.   
• Reproducibility: The ability of the biosensor to generate similar up to identical responses 
in repeated measurements. This reflects the high reliability and robustness to the 
response generated from the biosensor. It is an important characteristic of a precise 
transducer and electronic system in the biosensor.       
• Linearity: It reflects the accuracy of analyte measurement. For example, measuring the 
different concentration of analyte reflects a linear relationship, which can be 
mathematically represented by O= sc, Where O is the output signal, c is the 
concentration of an analyte, and s is the sensitivity of the biosensor. The concentration 
range of analyte that generate a linear biosensor response is called linear range. Linearity 
is also associated with the resolution of the biosensor, which is the smallest change in 
analyte concentration to generates a response in the biosensor.      
• User-friendly and mass-producibility: simple, low-cost, small, minimal sample size and 
pre-treatment, rapid measurement, and real-time analysis. 
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 Recently, researchers aimed to reduce the size of biosensors for many reasons. For 
instance, reducing the biosensor size to the micro- or nano-scale showed advantages such as  
increase the surface to volume ratio, improve the sensitivity and efficiency of detection, reduce 
the signal-to-noise ratio, lower sample size, and lowering the cost.131 
 Interestingly, the nanoscale electrochemical systems have lower double layer capacitor 
due to the decrease in the electrode area. Thus, the system has low solution resistance Rs and 
double layer capacitance Cdl  allowing ultra-fast electron transfer kinetics for detecting short-life 
species in short time, which can reach up to the nanosecond scale.130 It is also applicable to keep 
both Rs and Cdl constant to perform the detection without the need of supporting electrolyte.132  
 In terms of nanomaterials, the discovery of graphene sheets and metal oxides in different 
shapes are being reported in the literature, especially in electrode fabrication. Biosensors with 
further nanoscale fabrication can lower the detection limit more than previously reported and 
potentially improve future single-molecule detection.  
3.4.1 Silicon nanowires for biosensing⸻the state-of-art at present    
  Cancer biomarkers are used to predict the tumor prognosis. Since they are present in the 
tissue or blood in extremely low concentration, a highly sensitive detection method is needed. 
Several studies have used silicon nanowires as a biosensor for medical diagnosis. 133  
For example, prostate-specific antigen (PSA) normally excreted by prostate cells in very low 
concentration, while higher concentration is related to prostate cancer existence. The field of 
nano-sensing started with using silicon nanowires (SiNW), which was first reported by Liber’s 
group. n-type and p-type silicon nanowires were functionalized by monoclonal antibodies (m-
Ab) for three cancer markers: free protein-specific antigen (f-PSA), carcinoembryonic antigen 
(CEA), and mucin-1 showing high selectivity and sensitivity.134 Further, Kim et al. developed an 
ultrasensitive (n-type) SiNW- field effect transistor (FET) biosensor fabricated by a top-down 
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approach for detecting PSA. The detection sensitivity also increases to reach below fg/mL by 
decreasing the nanowire dimension because the n-channel with low density can be easily 
depleted by negatively charged molecules.135  
 MicroRNAs are another example of biomarkers, consisting of 20-24 nucleotides-long 
noncoding RNA molecules, involved in gene post-transcriptional regulations and affecting both 
the stability and translation of mRNAs in eukaryotic species. Existing methods are depending on 
indirect methods through hyperdilation to a complementary probe molecule or a labeled target 
miRNA. Thus, it is important to develop a direct detection method being simple with high 
selectivity and sensitivity. Zhang et al. 136 developed a free-label direct detection to miRNA (let-
7b) using immobilized peptide nucleic acid (PNAs) on the surface of SiNW. PNA is neutral and 
doesn’t have anionic phosphate backbone. This results in increasing the melting temperature and 
enhancing the RNA-PNA hybridization efficiency. Further, the detection of let-7b showed an 
increase in the resistivity corresponding to the increase in concentration from 1fM to 1nM.  The 
essay was further tested by extracting let-7b from Hela-cells. The let-7b was diluted with buffer 
solution and detectable concentration was 2.15 ± 0.25 × 107 copies/ µg RNA being acceptable 
when compared with previously published work using array-based Klenow enzyme (RAKE) 
assay. 137                
 Recently, only two groups applied SiNW for cell sensing application. Abdolahad et al.138  
fabricated a circular shaped sensing electrode with SiNW using thermal oxidation and being 
doped with c-phosphorus. The free label sensing electrode was used against another SiNW 
counter electrode forming a bioelectronic device to detect invasive colon cancer cells (SW48) in 
a mixed sample with another benign colon cancer cell line (HT29) in different ratios. Results 
showed different membrane dielectric properties reflecting the pathological condition of the cell 
before and after metastasis. Shashaani et al.139 used a similar electrodes configuration to test 
 
 28 
Mebendazole (MBZ, 2nM) drug effect on MCF7 by releasing Cytochrome C to its cytoplasm, 
which ultimetly changed the cells electrical activity (anodic/cathodic peaks). The changes were 
detected using cyclic voltammertry (CV) and differential pulse voltammograms (DPV).  
Alikhani et al.140 investigated the relation between acidosis (decrease pH) and electrical 
resistivity among breast cancer cells. The study reported that the most aggressive cell line 
(MDA-MB468) recorded higher electrical resistivity in acidic medium (pH 6.5) compared to 
moderate (MCF7) and sharp (MCF10) decrease in their resistance.140  
 Although silicon nanowires appear to be promising materials, they form a silicon dioxide 
(SiO2) layer (silica) when being exposed to oxidizing agents (e.g. air or water). This can affect 
electrical conductivity because SiO2 is an electrically insulating material and will ultimately 
affect the semiconducting properties that silicon nanowires might have.141  
3.4.2   Titanate nanowires for biosensing⸻the game changer 
 Various forms of TiO2 based materials such as nanotubes142, 143, nanoparticles144, 
nanosheets145, sol-gel macromatrics146, and 3D microporous material147 have been used 
extensively to develop biosensors for medical diagnosis.148  
 As mentioned earlier, the unique chemical and physical properties have attracted 
researchers to use titanate in different applications in the life science and medicine. Recently, 
titanate nanowire material has attracted attention to be used in bio-sensing technology. This is 
due to their unique properties of being semiconducting with high sensitivity to detect even a 
single molecule.4 Titanate based semiconductor nanowires can be grown on top of Titanium 
metal and in turn it can be used as an electrode to sense cancer cells.  These titanate nanowires 
can have their band gap varied between 1.8 and 4.1 eV, making it unique from other nanowires 
in giving the best sensitivity ranges. In addition, the titanate nanowires are easy to fabricate, hold 
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high biocompatibility and chemical stability.5 These properties make TiO2 nanowires an ideal 
material for biosensing applications.  
  So far, only a few studies have shown a promising use of TiO2 nanowires as biosensors. 
Wang and his coworkers have implemented TiO2 nanowire (TNW) microelectrode for detecting 
Listeria monocytogenes.149 A specific monoclonal antibody for Listeria monocytogenes was 
covalently attached on the TNW surface and placed in between two gold microelectrodes 
blocked with 2-methyl-2-propanethiol (SH-(CH2)3-CH3). The detection limit could detect as low 
as 102 CFU/mL of Listeria. Luo et al. demonstrated that TiO2 nanowires can be conjugated with 
cytochrome c and applied to detect H2O2 being secreted from liver cancer cells (Hep G2).150 
H2O2 is considered a metabolic biomarker for cancer cell characterization. The study showed 
linear amperometric responses for H2O2 over a broad range and low detection limit (2-100 mM). 
Recently, another group used TNW to immobilize Horseradish peroxidase (HRP) as a H2O2 
sensor.151 The detection limit reported is lower than the  previous study to reach 1.2	µM/mL with 
30-days stability, retaining 91% of its activity and showing fast and sensitive response compared 
with other biosensors made from different nanomaterials.   
To conclude, the TiO2-nanowire is a promising nanomaterial that showed promising 
biosensor capabilities. Few studies were done using TNW materials. Up this point, the usage of 
TiO2-nanowires to characterize and study the cell behavior under different pathological stages, 
stimulators, or pharmaceutical effects have not been reported. Thus, the purpose of this study is 
to introduce the TiO2-nanowires ability in recognizing the electrochemical properties of cancer 
cells and apply them to help in developing a prognostic tool for future diagnostic technology. 
This new method also can be potentially used in various important applications in cancer 




Chapter 4. Major Methods for The Characterization  
 
4.1 Power X-Ray Diffraction (PXRD) 
 X-ray diffraction (XRD) is long-used as a reliable method for characterizing a crystal 
phase. It tells the atomic and the molecular structures in a three-dimension (3D) crystal lattice. The 
XRD instrument consists of three main parts: X-ray tube, substrate, and the detector. When the 
monochromic X-ray striking on the sample, the scattering X-rays from crystallized atoms can 
interfere and diffract into a unique XRD pattern, as characteristics of the crystal lattice, that can 
be detected by the XRD detector. The PXRD is commonly used to identify the crystal phase, 
orientation, size and perfection of nanomaterials, based on the Bragg’s law: 
2dsin𝜃 = 𝑛𝜆, (1) 
 where the (d) is the spacing between two parallel and identical lattice-planes, (𝜃) is the 
XRD angle between the incident beam and the atomic plan in the 0-180° arrangement, (n) is an 
integer (order of the XRD), and (λ) is the wavelength of the incident X-Ray beam. Since the angle 
(𝜃) collected form diffracted beam and the wavelength are known, the lattice parameter (d) can be 
calculated from Bragg’s law, a. s explained in detail in the Fig. 4.1. 	Standards in Joint Committee 
on Power Diffraction Standers (JCPDS) or International Center for Diffraction Data (ICDF) can 
be used to identify the crystal structure of a new nanomaterial, which is a common practice in the 





Figure 4.1: Bragg’s Law illustration.   
  
4.2 Scanning Electron Microscopy (SEM) 
Compared to regular optical microscope, the SEM provides a higher magnification (10,000 
times more), higher resolution, and much clearer three-dimensional (3D) image with a much 
greater focal depth. Therefore, SEM is used commonly to characterize the topography and the 
morphology of the material of interest. The topography reflects the relationship between material’s 
surface feature and the properties of that material. On the other hand, the morphology reflects the 
nanomaterial’s shape, size and spatial organization that are all crucial to widely vary the 
nanomaterial’s properties and applications. 
An SEM is basically structured as shown in the Fig 4.2. The electron gun generates a 
focused beam of electrons from, commonly, a tungsten filament with a sharp loop-tip that emits a 
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narrow stream of electrons upon being heated by an electrical current.  The anode (accelerator) is 
located under the electron gun, using its negatively charged surface to repel negatively charged 
electrons thus focusing and accelerating them. The magnetic lenses are to focus the electrons on 
to the sample i.e. narrowing the beam of electrons to hit the sample.   
In the SEM sample preparation, the sample surface is coated with gold usually in a plasma 
sputtering coater under a vacuum form a mechanical pump. The surface gold coating provides an 
electric grounding path to prevent the electron-accumulation (charging) problem thus-getting a 
clear micrograph, on the SEM detector, of the sample surface topography.  
 
 
Figure 4.2. Schematic representation of the basic SEM components.  
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4.3 Electrochemical Impedance Spectroscopy (EIS) 
 Electrochemical Impedance Spectroscopy (EIS) is a well-established method widely used 
in biosensing, using an alternative current (AC) to detect electrochemical impedance. The 
impedance is defined as the ability of circuit to resist the flow of electrical current in a complex 
system, for measuring over a wide range of AC frequencies the dielectical properties of a material. 
EIS has been used in this work to develop a label free biosensor that hopefully can distinguish 
multiple electrochemical changes occurring at the same time. For example, it may identify the 
diffusion-limit of a passive film and the electron transfer rate of a reaction, the capacitive behavior 
of the system, etc.  
 In the impedance sensing experiment, an AC voltage signal (V(ω), usually sinusoidal) is 
applied as a frequency-dependent excitation. Then, a response (I(ω)) is measured (Fig. 4.3).43  
Zw = Ew/Iw ,  Z w= Frequency-dependent impedance, SI unit ohm (Ω) 
Ew = Frequency-dependent potential (voltage), mV  








Figure 4.3.  a) The phase shift between the voltage and current. b) The phase shift as an angle 







Phase shift between voltage and current can be expressed by (Fig 4.3 (a)):  
• excitation as f(t)                Et = Eo sin (wt) 
           Where: 
Et- potential at time t  
E0- amplitude  
w- radial frequency = 2𝜋𝑓  
f - frequency  
• response signal                  It = Io sin (wt + f)  
          Where: 
It - response at time t  
I0 - amplitude  
f	- phase  
The real (ZRE) and imaginary (ZIM) parts of the complex impedance are called resistance and 
reactance (Fig 4.3 (b)).  
4.4 Randal’s Equivalent Circuit  
 The electrochemical cell can be modeled by electrical circuit elements that be determined 
by EIS (Fig. 4.4), in which, 
Resistor, Z = R (Ohms), 0° Phase Shift                
Capacitor, Z = -j/wC (Farads), -90° Phase Shift       
Inductor, Z = jwL (Henrys), 90° Phase Shift 
j = √−1 
w = 2pf , radians/s,   f = frequency (Hz or cycles/s) 
A real response is in-phase (0°) with the excitation. An imaginary response is ±90° out-of-phase. 
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Warburg Impedance: It represents the resistance to mass transfer (diffusion control), 
and typically exhibits a 45° phase shift. Equations of equivalent circuit: 
 
Figure 4.4: The equivalent circuit, with the nanowire induction (L), nanowire resistance (R1), 
cell membrane capacitance (C2), cell membrane resistance (R2), intracellular matrix capacitance 
(C1), intracellular matrix resistance (RCT), and Warburg diffusion impedance (W01).  
 
 










The overall impedance of the circuit in (Fig 4.4) is given by: 








Equivalent Circuitry Parameters 
Determined Empirically in the 
Work 
Values 
L 1x10-7  
R1 50 (Ω)  
R2 10 (Ω)  
C1 1x10-6 (F) 
C2 2x10-6 (F) 
RCT 3 (Ω)  
 Sigma (𝜎) 0.0005 
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The Warburg impedance diffusion is described by  






Where 𝜎 is related to the diffusion coefficient of species in the cell (see Bard)152  
When separated in the real and imaginary components 

































Chapter 5. Materials, Chemicals and Experimental 
  
5.1 Materials and Chemicals 
 Titanium substrates (foil,0.25mm (0.01inc) thick, 99.99% metal base) was acquired 
from the Alfa Aesar, USA. Sodium Hydroxide (NaOH) pellets from Avantor performance 
martials, Sweden. Glucose was obtained from Sigma-Aldrich, Inc., USA. 
 Phosphate Buffer Saline (PBS) was prepared following the table: 
 
Table 5.1: Regents for preparing PBS (pH7.40, 1L) 
Chemical Maas (g) 
Sodium chloride (NaCl) 8 g 
Potassium Chloride (KCl) 0.2 g 
Sodium phosphate dibasic Na2HPO4 1.44 g 
Potassium phosphate dibasic KH2PO4 0.24 g 
 
 
   An 800 ml of deionized distilled (DDI) water was charged in an a one-liter polyethylene 
bottle and stirred with a magnetic stirrer while adding the chemicals in the order (Table 5.1). The 
pH was adjusted to 7.4 by titrating with a 1M HCl solution, the volume was adjusted to one litter, 
and the bottle was stored in a refrigerator at 4℃. 
 Four cancer cell lines, MCF-10A, MCF7, MDA-MB 231, and HCT 116 (all from the 
ATCC, USA) were obtained from Dr. Du’s and Dr. Shi’s labs (the first three) and Dr. Muldoon’s 
lab (the HCT116) on campus through collaborations. The MCF 10A is a normal human epithelial 
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cell line, MCF7 is a human non- invasive epithelial breast cancer cell line, MDA-MB231 is a 
human invasive epithelial breast cancer cell line. The HCT 116 is a colon cancer cell line.     
 
5.2 Experimental 
5.2.1 TiO2- nanowire hydrothermal synthesis 
A titanium sheet (from Alfa Aesar) of 1.5 cm ´ 2.0 cm in size was sonicated in 10 mL of acetone 
in a vessel for 15 min at room temperature (25ºC), then taken out and rinsed with DDI water (Fig 
5.1). Next, the Ti-sheet was placed in 10 mL of 1.0 (M) NaOH solution in a Teflon-lined vessel 
(Parr Instruments, Figure 5.2) that was sealed and hydrothermally heated in an oven at 160-250 
ºC for 4−8 hrs, then cooled in air outside of oven for 4− 24 hours. Thus-treated sample now, 
surfaced fully with the titanate nanowires-entangled scaffolds, was rinsed with DDI water until the 
surface reached pH » 7, and dried in air.5 Lastly, each sheet was scratched atop to expose metal 
for connecting the electrode, and epoxy-glued on rest edges and back, leaving a small front area 
sensing cells. 
 
5.2.2 The nanowire characterization 
5.2.2.1 X-ray Diffraction (XRD) 
 The phase purity and crystalline structure of the nanowires were characterized by X-ray 
diffraction (XRD) using Rigaku Miniflex X-ray diffractometer with a Cu Kα (λ=1.5405Å) 




























Figure 5.2: The autoclave chamber (left) and the Teflon liner (23mL) (right). 
 
 
 Sealing in Teflon liner/Autoclave Vessel  
Titanium (1.5 cmx1cm)   
Sonication: 10mL of acetone for 15 min  
Rinse: Deionized water 
Anneal: 160-250ºC for 4-8 hrs 
Mix solution  : 1M NaOH in 10mL DDI 
H O  
Cooling for 4 hrs 
Wash: Deionized water until pH=7 




5.2.2.2 Scanning electron microscope SEM 
 The morphology of the nanowire scaffolds was examined under a scanning electron 
microscope (SEM, Tescan SEM VEGAII SBH) performed at 30kV. Both top and cross sections 
of TiO2-based nanowire.  
 
5.2.2.3. Point-of-Zero-Change (PZC) of H-Titanate nanowires 
 To estimate the PZC of the TiO2-nanowire, a range of different pH from 2 to 12 were 
prepared by using 0.1 M of hydrochloric acid (HCL) and 0.1 M of sodium hydroxide (NaOH) in 
the DDI water. The pH was checked by the pH meter. The aqueous solutions containing the sample 
were rotating overnight at room tempreture. The rotating will allow the nanowire to be exposed to 
the different pH solution. The clear solution will be used to measure the final pH using the pH 
meter and the result of initial and final pH will be used to determine the Point-of-Zero-Change 
(PZC).153    
 
5.2.2.4 Impedance characterization of the nanowires  
 The platinum (Pt) was the counter electrode. The titanate scaffold sheet in a similar initial 
impedance curve was used as background. The impedance was tested by means of a Gamry 
Potentiostat (Reference 600, Gamry Instrument, USA), with the parameters of 5mV AC and 




Figure 5.3: Schematic illustration for the set-up and corresponding equivalent circuitry.  
  
5.2.3 Bioimpedance cell sensing on the titanate nanowires  
 
5.2.3.1 Impedance test for breast cancer cell lines  
This test was carried out to determine if the biosensor can distinguish the cancer cells 
pathological malignance. The frequency was swept to determine range giving the a clear 
impedance difference (separation) between the cancer and normal cell line. At least three 
such biosensors having similar initial impedance curve were incubated in a 10ml (1´PBS) 
solution containing one million (106) cells/ml for 35 minutes at room temperature (25℃), 
with each of the three breast cells lines (MCF10A, MCF7, and MDA-MB 231) and one 














5.2.3.2 Impedance test for breast cancer cell lines at various incubation frame  
Cells where incubated in different time intervals (25, 35, and 45 minutes). The impedance 
was recorded for the three cell lines (MCF10A, MCF7, and MDA-MB 231) to determine the 
best incubation time to do the impedance test as described earlier. The parameters setup was by 
changing the frequency starting from 30 kHz till 1MHz. 
 
5.2.3.3 Impedance test for normal and breast cancer cell lines in mixed sample 
This test aims to determine if the biosensor can detect the presence of abnormal cells within 
the normal population and can distinguish the pathological stage of cancer cell. Both cancer cells 
lines (MCF7 and MDA 231) where mixed with normal cell line (MCF10A) in different (cancer 
cell: normal cell) ratios (1:100, 1:50, 1:25, 1: 10, 1:5). The parameters setup was by changing the 
frequency starting from 30 kHz till 1MHz. 
 
5.2.3.4 Impedance test for breast cancer cell lines at 37℃ 
This test was conducted to determine if the tempreture affect the different cell impedance. 
The cancer cell lines and the biosensor (TiO2) where incubated for 35 minutes. Impedance test was 
done as described previously under two different tempreture, 25 and 37℃. The parameters setup 
was by changing the frequency starting from 30 kHz till 1MHz. 
 
5.2.3.5 New impedance test for glucose effect on the breast cancer cell lines 
 This test was done to investigate the effect of glucose on the cancer cell behaviors and in 
turn the impedance readings. The four cell-lines (MCF10A, MCF7, MDA-MB231, and HCT116) 
were suspended in a 10mL 1´PBS containing 5.5 (mM) of glucose. The impedance test was done 
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as described in the above. The parameters setup was by changing the frequency starting from 40 
kHz till 1MHz. 
   
5.2.3.6 New impedance test for Doxorubicin effect on the breast cancer cell lines. 
 This test was performed to investigate the effect of a well-known chemotherapy drug 
Doxorubicin on two different cancer cell lines. MCF7 is known to be more resistive to DOX than 
MDA-MB231.154 To investigate the cell impedance change due to the DOX, the two cell lines 
were first cultured to reach 90% confluence and then the DOX (2𝜇M) was added over two time-
intervals, 24 hours and 48 hours. The cells were then harvested using trypsin and counted using 
the hemocytometer and trypan blue stain to control the cell number. The cells were then suspended 
in 10mL of 1´ PBS with the TiO2-nanowires sensor for 35 minutes, and the impedance was tested 
likewise from 40 kHz to 1MHz. 
 The second set of experiment was done as in the first step, with glucose (5.5 mM) in the 
cell suspensions to investigate the cell impedance correspondence to glucose effect after being 
treated with DOX. The biosensors were done after 35 minutes in the cell suspension, with the 
impedance parameters same as described previously. 
 
5.2.4 Microscopic visualization using Fluoresce staining 
 After the data collection, the three scaffolds were dyed with SYTO®24 Green-
Fluorescent Nucleic Acid stain (from Life Technology) with 490 absorptions and 515 emission 
wavelengths to visualize the attached cells. After fluorescence images were taken by Olympus 
BX41 microscope, cells were detached with trypsin and washed until no significant fluorescence 
could be seen. The test confirms the attachment of cells to the TiO2- nanowire surface and 
confirming that the change in nanowire resistivity is coming from cell attachment.  
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5.2.5 Error analysis  
 All experiments were repeated three times using the same TiO2-nanwire scaffold. All cell 
suspension contains the same cell number/ml. All data are expressed as mean ± standard 






















Chapter 6. Results and Discussions 
 
In Fig. 6.1, the intermediate sample (4hrs reaction) looks dark grey, and the final product 
of the nanowire-covered surface seems grayish, both far from the Ti-metal that looks like the 







Figure 6.1: The physical morphology of titanate after the hydrothermal treatment.  
 
6.1 Nanowire Characterization 
6.1.1 Powered X-ray diffraction (PXRD) 
 The PXRD study was conducted to characterize the crystallinity and structure of the 
nanowires grown directly on the Ti-metal surface. The Fig. 6.2 shows the PXRD pattern of a 
typical sample with the nanowires grown in situ on the Ti-metal. Comparing with the data 
reported by others including those from our same lab in literature 5, the five peaks at the 2-theta 
values of 32, 34, 36, 38.5, 40 ,53, 70, and 78 belong to the Ti-metal under the nanowires, while 
the rest peaks at the 2-theta values of 10, 24, 28, 48, 50 match the clay-like layered structure of 



















Figure 6.2: PXRD pattern for titanate nanowire pattern of a typical sample with the titanate 
nanowires on the Ti-metal after 24 hours of the hydrothermal treatment (see the discussion on 
the time-study below).   
 
6.1.2 Scanning electron microscope SEM 
 As schematically illustrated in the Fig. 6.3, the SEM micrographs illustrated the growth 
and entanglement of the nanowires in the hydrothermal reaction on the Ti-metal. After the 
hydrothermal treatment for 4, 8, and 12 hours, the nanowires grew long enough over time to start 
to naturally entangle atop, self-assembling into the bioscaffolds with “bird-nest” like concaves (i.e. 
cell-nest) on the sample surface, as depicted in the cross-section images in the Fig. 6.4. Further 
prolonging the reaction time to 7, 18, and 24 hours, respectively resulted in slightly better 
developed and organized cell-nests (Fig.6.5). On this basis, the samples from 8-hours of the 
hydrothermal growth with enough well-developed “cell nests” were chosen to support the low-
cost, quantitative, label-free, and real-time detections and differentiations of cancer cells for the 
first time on a smart bioscaffold.  
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Figure 6.3: A schematics for illustrating the change on the Ti-metal surface after the 











Figure 6.4: The SEM study on the nanowires from the growths over the 4, 8, and 12 hours. 
Hydrothermal  















Figure 6.5: The SEM characterization of the bioscaffolds on the typical sample from 8-hour 
hydrothermal synthesis. (a). The face-on view on the sample-top; (b). The tilt view. 
 
6.1.3 Point-of-Zero-Change (PZC) on H(Na)-Titanate 
 To understand the surface cation exchange of titanate nanowire, a simple pH-titration was 
conducted to estimate, on the nanowire surface, the point of zero charge (PZC) value from the 
equilibrium between the H+ on the nanowire surface and that in the solution. In the plot of the 
initial vs. final pH values (Fig. 6.6), the flat region’s pH is often regarded as the PZC.153 
Accordingly, the nanowire’s surface ion-exchanged protons (H+) (i.e. Lewis acid) and 
surface hydroxide (OH-) (i.e. Lewis base) groups can co-affect the average surface acidity/basicity 
at the nanowire-water interface. This further suggests (i) the continuous H+↔Na+ ion-exchange 
can make the nanowire surface to buffer between pH 4 (of the hydrogen titanate) and pH 10 (of 
the sodium titanate),155 (ii) the capacity and kinetics of nano-buffering may reflect the 
completeness of intercalation of the Na+ with the H+ on the titanate nanowire,  (iii) the negative 
framework made of (Ti3O7)-2  tend to be a multi-deck Lewis base host, as H+  is a strong but Na+ 
is a week Lewis-acid guest. This new insight of the surface dynamics in the solution surface 
nanochemistry and “conjugated acid-base” nanochemistry supports that a controlled time (i.e. 
500 µm 




b)   Cross-sectional tilt SEM view  
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degree) of the DDI washing (i.e. H+ exchange) can convert the nests of as-made Na-titanate 
nanowires to that of a H(Na)--titanate nanowire with a PZC at/around the pH 7 for doing the cell-
biosensing. 
 
Figure 6.6: Point of zero charge (or isoelectric point) of the DDI-washed titanate nanowires 
from the titration between pH 1 and pH 12.    
 
6.1.4 Impedance characterization for the titanate nanowires-entangled cell-nests 
 A series of (1×) PBS solutions between pH 4 and pH 8 were used to quantify the effect of 
pH on the impedance of the titanate nanowires-entangled cell-nest (Fig. 6.5). The result shows a 
clear correlation between the impedance and solution pH, in which the impedance increases 
generally with the pH. This correlation can be explained again with the Lewis acid/base theory. 
In the aqueous solution, the hydroxyl group on the nanowire surface was deprotonated and 
negatively charged when the pH ~ 7 (i.e. above the PZC point). On the contrary, the surface -OH 
groups being protonated (gain H+) will be positively charged at the pH < PZC point.153  This is in 
line with such a fact that an oxide in an aqueous solution above (or below) its PZC the surface 



















proton transfer thus no further change to the PZC point. Thus, the electrical impedance of the 
nanowires (with the poor electrical conductivity) is commonly used to quantify such surface-
PZC point shifting corresponding to the mass transfer of ions of any type in a confined area. 
Equivalently, when the solution pH decreases, the nanowire surface is more protonated, gaining 
more positive charges on the nanowire surface to facilitate a faster charge-transfer along the 
nanowire surface and to reduce the impedance. This supports Fig. 6.7 and in turn how crucial the 














































Figure 6.8: Illustration of surface deprotonation and protonation corresponding to the aqueous 
solution pH change. 
 
6.2 Impedance Sensing of Live Cell on the TiO2-Nanowires.   
Characterizing individual cancerous cells from the blood stream i.e. the circulating tumor 
cells (CTC) tumors using a simple and quick impedance test is of importance to support both 
qualitative and quantitative cancer pathology beyond the current practices using either staining or 
optical imaging that are slow, labor-intensive and expensive. When cancer cells of the malignant 
and benign subtypes look similar from one another using the staining and optical imaging. 
However, the subtypes difference in metabolism should enable us to develop an alternative 
diagnostic tool with negligible false-negative and false-positive problems, which has been 
underexploited. Such new method should rely on the cancer cells’ metabolic wastes among 
which the ionic spices can change our nanowire-bioscaffold surface’s charge-transfer pattern, 




6.2.1 Impedance test for breast cancer cell lines over the sensing time 
Cells contain an intracellular medium surrounded by a semipermeable membrane, which 
separates the extracellular from the intracellular ionic solutions using the cell membrane made 
from a lipid bilayer, proteins, and some poly-saccharides. The membrane exhibits capacitive 
properties due to the electrical potential difference between the membrane’s two sides, and the 
impedance of cell membrane’s capacitance changes with the frequency. At low frequency, the 
cell membrane is more like an insulator, resulting a higher impedance (i.e. highly resistivity) that 
allows current in the extracellular medium. When the frequency is high, the cell membrane is 
like a capacitor and starts to conduct charges and allow the current to go through the membrane, 
thus-reducing the impedance signal.       
In our experiment, more cells were attached onto the nesting nanowires over long time 
after the bioscaffold-sensor was inserted in the PBS solution containing the cells. Different cells 
upon attaching onto the nanowire-nest surface can instantly change the nanowires’ impedance 
differently. After the attaching for about 35 minutes, normal breast cells (MCF10A) shift the 
impedance by 40−50 ohms at the high frequency range (1MHz) (Fig. 6.9), while the benign 
breast cancer cells (MCF7) shift that to about 60 ohms (Fig. 6.10), and the malignant breast 
cancer cells (MAD 253) can do so by 80 ohms (Fig. 6.11). The Figs. 6-11 suggest that the net 
surface charge for the three cell lines are different, therefore, they change the nanowires surface 





Figure 6.9: Impedance vs Frequency for normal cells (MCF10A) in three-time frames (25,35, 





































Figure 6.10: Impedance vs Frequency for benign cancer cells (MCF7) in three-time duration 



















































Figure 6.11: Impedance vs Frequency for malignant breast cancer cells (MDA-MB231) in three-







































Figure 6.12: Impedance vs Frequency for three breast cancer cells (MCF10A, MCF7, MDA-






















































Dobrzynska156  and coworkers did the electrophoresis to study the changes of surface 
electrical properties as a function of pH for the same cell lines, on a four-component equilibrium 
model with a negligible variation between the experimental and theoretical charge in the pH 
range of 2.5−9.0. In studying the mammalian cells, the pH was kept narrowly between 6 and 8, 
which the cell membrane proteins can be maintained during the electrophoresis. The results 
revealed that at a lower pH the charge density on the cancer cells surface gets more positive, 
meaning more protonated. Their findings concluded that this increase is related to the acidic 
(CTA) and basic (CTB) functional groups’ average association constant for hydroxyl ions (KOH) in 
the breast cancer cell membrane, especially in MDA 231, which is higher than that in normal cell 
(i.e. MCF10A) membrane.  
From the plasma membrane proteomics,157 the cell membrane proteins are elevated in 
MDA 231, comparing with the MCF7 and normal (MCF10A) cells, and the keratin type I 
Cytoskeletal 17 (KRT17) is present only in the normal cell. As the cell turns malignant, this 
cytoskeletal filament disappears i.e. being replaced by Keratin type I Cytoskeletal 19 (KRT19) 
that was found to be higher in the MCF7 cell-membrane. Vimentin (VIM), a cytoskeletal 
filament mostly expressed in mesenchymal stem cells, is highly expressed in the aggressive 
cancer cell (MDA-MB231). Microtubule-interacting protein 1B (MAP1B) was only found in 
MDA-MB231, while the subtype (MAP4) was found in both MCF7 and MCF10A. Myosin 
regulatory light chain 12B (MYL12B), important in maintaining the cell structure, was found 
only in MDA-MB231. Further, the MDA-MB231 have more cytoskeletal filaments and some are 
abnormally expressed. These are important to cause the resistivity changes by e.g. lowering the 
water content in the cell. These variations can be measured using the impedance to quantify the 
mass-transfer outside the cells at low frequency and that across the cell membrane (e.g. into the 
cytoplasm) at high frequency.  
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Further, the lipid bilayer was investigated to show the cancer cell membrane with fewer 
fatty acids and phospholipid types.158 Interestingly, that study found that cancer cells produce 
more positively charged phospholipids, e.g. (PE 36:2) in MCF7 and (PC 32:0, PC 36:2, PI 36:1) 
in MDA-MB231. Among the fatty acids, mostly are the oleic acid (C18:1) and palmitoleic acid 
(C16:0) in MCF7, and the oleic acid (C18:0) and docosahexaenoic acid (C22:6) in MDA-
MB231. The presence of such unsaturated fatty acids within the cell-membrane bilayer increases 
the cell membrane’s fluidity, flexibility, and permeability along with the pathological 
malignancy of the cancer cell. Other studies reported an elevated phospholipid production in the 
same cell-lines.156, 159, 160 This overproduction is often correlated to a tumorigenic transformation.  
This is because in the tumor’s external microenvironment, the pH is more acidic (pH 6.5) hence 
the cancer cell surface net-charge is more positive, as the surface carboxyl, amino and phosphate 
groups are protonated. Therefore, increasing the number of cell surface phospholipids lead to a 
more negative surface charge density at high pH but a more positive charge density at low pH.  
In breast tumor, the sialic acid was lately found to be upregulated which affects the cell 
membrane charge, and in turn the acid and basic groups on the cell membrane160. Thus, a knock 
out to an important gene in the sialic acid metabolism disabled the production of the active form 
of sialic acid and helped lower the lung cancer metastasis rate in vivo.161  
In addition, the reactive oxygen species (ROS) can affect membrane lipids and proteins in 
the acidic environment, via triggering a lipid peroxidation process. Consequently, phospholipids 
in the inner lipid layer such as phosphatidylserine (PS) expose to the outside, thus-increasing 
both the acid group’s content on the cell surface156, and the level of KBOH comparing with the 
original cell-membrane.  
All these reports in the literature consistently support that the transformation in cell 
membrane structural lipid and protein composition can cause the increase in resistivity due to 
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exposure of negatively charged groups. In turn, the higher resistivity can lower the cell’s outer 
layer potential, which further increases the resistivity of the cancer cell membrane and supports 
the selective quantitative cell-sensing and cell-type characterization. 
 
6.2.2 1st impedance test for distinguishing breast cancer cells from colon cancer cells 
An important question to be answered in this project is whether there is a difference in 
the surface charge density of cancer cells developed in different part of the body, e.g. colon 
cancer cells vs. breast cancer cells (Fig. 6.13). The breast cancer cells showed an increase in the 
impedance level corresponding to the cell’s pathological malignancy. However, an opposite 
response was observed from the same sensing of an aggressive colon cancer cell (HCT 116) on 
the same set of the biosensors. This HCT 116 cell line has turned the nanowire-surface to be 
more conducting from apparently a lower impedance level. With little being reported in literature 
based on our thorough literature survey, the impedance data can guide future cell-biology study 
on the proteins and lipids in the HCT116 cell’s membrane that are different than that in the 
breast cancer cells’. Further, modifying the breast cancer cell line membrane’s protein and lipid 
constitution may help tell what opposite charge density is in the HCT116 cell with, probably, 
more amino groups on its surface at the experimental pH 7.4 being protonated to hold a positive 
net surface charge thus-making the bioscaffold-nanowire to be more conducting.  Since the 
breast tissue (neutral) have different pH in nature than the colon (basic), the colon cancer cells 





Figure 6.13:  Impedance test for normal cell and different cancer cell types. 
 
In the Nyquist plot (Fig. 6.14) with the real (ZRE) and imaginary (ZIM) parts of the complex 
impedance, each cell-line has a characteristic impedance level. Unusually, an induction effect 
exhibits clearly on every thus-made bioscaffold, due apparently to the nesting nanowires circularly 
self-assembling into each nest. In other words, the current moves on each nanowire surface from 
the bottom to the top of the nanowire in a circular manner for spirally electric field reaching the 
surface of each nest, thus-creating an inductive electromagnetic field for the nano-induction effect. 
This effect was not observed in pure Ti-metal working electrode, which means that the induction 
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    6.2.3 Impedance test for breast cancer cell and normal cell lines in different mixing ratios 
This work aims to study how the impedance signal would change when the breast cancer 
cells and normal cells be mixed together. In this experiment, the MCF10A normal cells were mixed 
with the MCF7 and MDA 231 cancer cells, respectively, each across a wide range of mixing ratios, 
from 1:1,00 to 1:5 (Fig. 6.16). In the Fig. 6.16, a linear correlation between the lower mixing ratio 
and the higher corresponding impedance can help quantify how many cancer cells being mixed in 
the normal cells. This method, if combined with a simple cytofluorometry (for knowing the total 
number of cells), can be useful to detect the CTCs in a mixture with other cells, because other lab 
reported a 5% increase of the impedance from one cancer cell in 100 normal cells.58   
In literature, a study on these three cell-lines correlated a lower capacity with a higher 
malignance, due to the increase in the cell permeability for the pathologically more aggressive 
cancer cell.60 An electrophoresis study on the same three cell-lines showed significant differences 
in the cell membrane net-charge, showing cancer cells’ more negative electric properties towards 
negativity more than observed in normal cells.156  These reports match our study, co-suggesting 
that our label-free nano-EIS sensor can distinguish normal from cancer cells, and differentiate the 





















Figure 6.16: Impedance at 1 MHz for mixed sample.   
6.2.4 1st impedance test for the Warburg effect on breast cancer and colon cancer     
cell-lines 
The aim of this experiment is to quantify the effect of an electrically neutral metabolic fuel 
on the cancer cells, which is underexploited so far on an electrochemical nanosensor, but useful 
for quantifying and even characterizing cancer metabolic wastes, which is important in the basic 
cancer biology. In Fig. 6.17, the cancer cells shifted their impedance level from above to below 
the base line differently from the normal cells, indicating that the normal and cancer cells secret 
different metabolic wastes each in a unique charge density to affect the nanowire-surface charge 
uniquely.  
As discussed in the Chapter 2, cancer cells consume glucose and secrete lactic acid as a 
metabolic waste (i.e. Warburg effect), with a consistent upregulation of genes for the glucose 
transport and glycolysis,15-17 and the glucose transporters overexpress in hepatocarcinomas as 
y = 9.009x + 65.121
R² = 0.9516
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well.18-20 By consuming more glucose than individual cancer cells, a tumor secretes a massive 
amount of lactate aiming to toxify the nearby normal cells more intensively, which can potentially 
result in a much stronger impedance signal on our bioscaffold sensor. 
In cancer biology, under the help of overexpressed GLUT-1 that is activated by the HIF-
1protein, cancer cells tend to have a higher intake of glucose results in more production and 
secretion of the negative-charged lactic acids. Thus-increased [H+] on the nearby nanowire surface 
and increased in he nanowire-surface conductivity and lowered the impedance level, which is 
supported by the pH study in the Fig. 6.7. The MCF7 and MDA 231 cancer cells each showed a 
significant shifting (Fig. 6.17) in their impedance level (see the red and blue arrows) after allowing 
the cells to intake the glucose, thus-proving the Warburg effect for quantifying and characterizing 
the cancer and normal cells directly on our smart bioscaffold-turned nanobiosensor. 
In general, different types of cancer cells may secret different metabolic wastes as the 
biomarkers.  For example, the HCT 116 cells metabolism162 from an increase in the 𝛽-oxidation 
and urea cycle metabolism secrets four main metabolic wastes: N-acetylputrescine,  
Phenylacetylglycine, Deoxycarnitine or gamma-butyrobetaine (GBB), and Butyrylcarnitine.162  
These four metabolites each has an amide group in the structure. This explains why HCT 116 act 
differently from other breast cancer cells on the titanate nanowire-bioscaffold.  Overall, different 
cancer cells secrete different metabolite wastes as the cell’s biomarker that if showing a charge in 





Figure 6.17: (a) Impedance test for different cancer cell lines with no glucose in 1xPBS. (b) 
Impedance test for cancer cells compared to normal cell incubated with 1xPBS+ 5.5mM glucose.  











































6.2.5 Impedance test for the temperature effect on the breast cancer cell lines at 
37℃ 
The abovementioned impedance tests done at room temperature (25℃) have raised a 
question regarding whether, and if yes how, the temperature that affects the cancer cell 
metabolism would change the impedance level at human body temperature 37oC?	 In this 
experiment, the MCF7 and MDA 231 cells were attached on the bioscaffold, respectively over 
35 minutes at 37oC	, and the impedance tests were done at the same tempreture. The impedance 
level for MCF7 and MDA 231 breast cell lines show no significant shifting in impedance signal 






























6.2.6 1st impedance test for the doxorubicin drug effect on the breast cancer cell       
            lines 
Doxorubicin (DOX, in a chemical formula of C27H29NO11), also called AdriamycinTM, is a 
popular chemotherapy drug for treating several types of cancer including breast cancer via 
triggering the cancer cell death. This drug was used to quantify the drug effect on breast cancer  
cells’ metabolism in response to stresses from different dosages of the DOX, via monitoring the 
impedance signal change from the cancer cells before and after the DOX treatment. The drug 
cytotoxicity was assessed to determine the concentration of 2.0	(µM), which the cancer cells start 
to die in a proper pace that can enable us to quantitatively characterize the DOX effect on the 
cancer cell’s metabolism and apoptosis directly on the smart bioscaffold (Fig. 6.19). 
The DOX is supposed to decrease the MCF 7 impedance due to cell’s resistance to the 
DOX.163, 164 This is because the overexpressed P-glycoprotein 1 (P-gp), also called multidrug 
resistance protein 1 (MDR1) or ATP-binding cassette sub-family B member 1 (ABCB1) or 
cluster of differentiation 243 (CD243), can pump the foreign molecules out of the MCF 7 cell.165  
 Due to MCF7 cell’s resistance to DOX, incubating MCF7 with glucose helped MCF7 cell 
to flush the pre-absorbed DOX out to the extracellular solution, which should result in a higher 
impedance on the bioscaffold at low frequency due to the DOX negative in charge at 
physiological pH 7.4 (Fig. 6.20). In contrast, the MDA 231 cells, with a much lower resistance to 
DOX, should show a lower impedance under the same condition, and no significant response to 




































MCF7+ DOX (24hrs) 











Figure 6.21: (a) MCF 7 impedance test corresponding to DOX and IPMF. (b) MCF7 impedance 














Figure 6.20: (a) Impedance test for MCF7 treated with DOX for 24 and 48 hours. (b) Impedance 
test for MCF7 treated with DOX for 24 hrs and then incubated with glucose for 35 minutes 



































Curving fiting parameter: 
R1= 50, Rct = 1003 
C1= 0.00000002 
C2= 0.0000005 
Apparently, sensing the DOX (out of 





Figure 6.21: Impedance test of MDA-MB231 treated with DOX for 24hours and being 
incubated with glucose before the test.  
 
6.3 Checking the cell attachment under the optical microscope 
Before and after the impedance, the normal and cancerous cells on the bioscaffold were 
checked under the optical microscope. As can be seen in the Fig. 6.23, the cells population 
change on the bioscaffold was negligible, which supports why the impedance cell-sensing was 



















MDA-MB 231 treated with DOX (24 hours) 


































Figure 6.22: Optical microscopic images of the cells on bioscaffold. (a). without stain; (b). with 

























Chapter 7. Conclusion 
 
The bioscaffold sensor can differentiate the pathological stage for the benign and malignant 
cancer cells. The different cancer cells from different origins (e.g. colon cancer vs. breast cancer) 
showed different impedance responses upon binding and metabolizing to the nanowire surface, to 
date never reported in literature, which will help collect new data for advancing the cancer biology. 
Mixing cancer cells with normal cells over a wide range has further validated this new cell-sensing 
technology. Quantifying the cancer drug’s efficacy has been ongoing using other drugs old and 
new to the market.  The sensing for the glucose effect showed a partial reversibility of the cancer-
drug effect different for different types of the cancer cells. On this basis, the characteristic 
fingerprints of cancer cells have been concluded in the Fig.7.1 for MCF7 cells, and in the Fig.7.2 
for the MDA-MB231, which may change the game in today’s cancer-pathology labs, via thus-














Figure 7.1: MCF7 characterization  
 
 










































Chapter 8. Future work 
 
The findings from the experiments that are summarized in this dissertation have urged us to 
propose some low-risk, high-gain future work in the following: 
1- To determine the impedance of more shapes, sizes and types on the smart bioscaffold.  
2- To improve the sensitivity of the bioscaffold to the highest toward detecting single (or 
single digit) cell(s).   
3- To expand the impedance sensing technology to covering all kinds of charge species 
besides the biological cells. 
4- To study the impedance of tissues, bacteria, virus, eggs, and live insects on the 
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